COVAX | WCMFX | COVAX / WCMFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 5 years | - |
Gain YTD | -0.415 | 16.271 | -3% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 100000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.03B | 76.8M | 1,339% |
Annual Yield % from dividends | 1.26 | 0.00 | - |
Returns for 1 year | 9.34 | 30.94 | 30% |
Returns for 3 years | -18.46 | 21.43 | -86% |
Returns for 5 years | 15.91 | N/A | - |
Returns for 10 years | -2.05 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TIRGX | 18.59 | 0.23 | +1.25% |
T. Rowe Price Global Real Estate I | |||
DRLYX | 8.99 | 0.09 | +1.01% |
BNY Mellon Developed Markets RE Scs - Y | |||
VISGX | 76.98 | 0.53 | +0.69% |
Vanguard Small Cap Growth Index Inv | |||
MWOFX | 66.85 | 0.22 | +0.33% |
MFS Global Growth A | |||
TPLGX | 77.87 | 0.23 | +0.30% |
T. Rowe Price Instl Large Cap Core Gr |